Influence of fracture criteria on the outcome of a randomized trial of therapy

Osteoporosis International

Volumn 8, Issue 2, 1998, Pages 184-191

  Melton III, L J ^a   Egan, K S ^a   O'Fallon, W M ^a   Riggs, B L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Diagnostic criteria; Incidence; Randomized clinical trial; Vertebral fracture

Indexed keywords

FLUORIDE SODIUM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORPHOMETRICS; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VERTEBRA FRACTURE;

EID: 0031981711     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02672517     Document Type: Article

References (29)

1. Anonymous. Assessing vertebral fractures. National Osteoporosis Foundation Working Group on Vertebral Fractures. J Bone Miner Res 1995;10:518-23.
2. Black DM, Palermo L, Nevitt MC, et al. Comparison of methods for defining prevalent vertebral deformities: the Study of Osteoporotic Fractures. J Bone Miner Res 1995;10:890-902
3. Melton LJ III, Lane AW, Cooper C, Eastell R, O'Fallon WM, Riggs BL. Prevalence and incidence of vertebral deformities. Osteoporos Int 1993;3:113-9.
4. Black DM, Cummings SR, Stone K, Hudes E, Palermo L, Steiger P. A new approach to defining normal vertebral dimensions. J Bone Miner Res 1991;6:883-92.
5. McCloskey EV, Spector TD, Eyres KS, et al. The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int 1993;3:138-47.
6. Burger H, Van Daele PLA, Grashuis K, et al. Vertebral deformities and functional impairment in men and women. J Bone Miner Res 1997;12:152-7.
7. Eastell R, Cedel SL, Wahner HW, Riggs BL, Melton LJ III. Classification of vertebral fractures. J Bone Miner Res 1991;6:207-15.
8. Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ III. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 1992;7:221-7.
9. Ettinger B, Black DM, Nevitt MC, et al. Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1992;7:449-56.
10. Ross PD, Huang C, Karpf D, Lydick E, Coel M, Hirsch L, Wasnich RD. Blinded reading of radiographs increases the frequency of errors in vertebral fracture detection. J Bone Miner Res 1996;11:1793-800.
11. Cooper AM, Melton LJ III, Eastell R. The development of algorithms for defining vertebral deformities. In: Genant HK, Jergas M, van Kuijk C, editors. Vertebral fracture in osteoporosis. San Francisco: Radiology Research and Education Foundation, 1995:253-60.
12. Riggs BL, Hodgson SF, O'Fallon WM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990;322:802-9.
13. Genant HK, Jergas M, Palermo L, et al. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1996;11:984-96.
14. Kanis JA, McCloskey EV, Khan S, Nakatsuka K, Sirtori P. What is a vertebral fracture? In: Christiansen C, Riis B, editors. Proceedings of the fourth international symposium on osteoporosis and consensus development conference. Aalborg: Handelstrykkeriet Aalborg, 1993:26-8.
15. Food and Drug Administration. Draft guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis. Division of Metabolism and Endocrine Drus Products, FDA, Rockville, MD, August 1993.
16. Leidig G, Storm T, Genant HK, et al. Comparison of two methods to assess vertebral fractures. In: Christiansen C, Overgaard K, editors Osteoporosis 1990. Copenhagen: Osteopress, 1990:626-8.
17. Wu CY, Li J, Jergas M, Genant HK. Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures. Osteoporos Int 1995;5:354-70.
18. Pak CYC, Ho A, Poindexter J, Peterson R, Sakhaee K. Quantitation of incident spinal fractures: comparison of visual detection with quantitative morphometry. Bone 1996;18:349-53.
19. Nelson DA, Kleerekoper M, Peterson EL. Reversal of vertebral deformities in osteoporosis: measurement error or 'rebound'? J Bone Miner Res 1994;9:977-82.
20. Riggs BL, O'Fallon WM, Lane A, et al. Clinical trial of fluoride therapy in postmenopausal Osteoporotic women: extended observations and additional analysis. J Bone Miner Res 1994; 9:265-75.
21. Chao EY, Laging BJ, Bleimeyer RR, Riggs BL, Yamagata M, Schroeder LN. Biplanar stereo roentgenographic method for determining vertebral fracture in postmenopausal osteoporosis. Orthop Trans 1985;9:313.
22. Rab GT, Chao EY. Verification of roentgenographic landmarks in the lumbar spine. Spine 1977;2:287-93.
23. Riggs BL, Melton LJ III, O'Fallon WM. Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. Bone 1996;18:197S-201S.
24. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993;8:1137-48.
25. Inkovaara JA, Heikinheimo R, Jarvinen K, Kasurinen U, Hanhijarvi H, Iisalo E. Prophylactic fluoride treatment and aged bones. BMJ 1975;III:73-4.
26. Dambacher MA, Inner J, Ruegsegger P. Long-term fluoride therapy of postmenopausal osteoporosis. Bone 1986;7:199-205.
27. Kleerekoper M, Peterson EL, Nelson DA, et al. A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis. Osteoporos Int 1991;1:155-61.
28. Mamelle N, Meunier PJ, Dusan R, et al. Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet 1988;II:361-5.
29. Pak CYC, Sakhaee K, Adams-Huet B, Piziak V, Peterson RD, Poindexter JR. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride: final report of a randomized controlled trial. Ann Intern Med 1995;123:401-8.